The online screener survey will be available on March 16 through Verily’s Project Baseline, the genomic database project launched by Alphabet’s life sciences arm in 2017. Those found to be eligible for further testing will then be directed to new mobile testing sites, which will provide results within a few days.
The program will initially launch in the San Francisco Bay Area, with expansion planned as more testing kits and locations are made available.
A March 15 announcement about the pilot project notes that the information collected in the online screening and in-person testing will not be shared with insurance or medical providers without patients’ consent, nor will it be used for advertising.
Read more here.
More articles on consumerism:
Lyft extends partnership with patient transportation platform
UnityPoint leads $16M funding for patient data management startup
CVS Health adds Livongo, Hinge Health & more to digital health platform
